Schnyder corneal dystrophy

From WikiMD's Wellness Encyclopedia

Schnyder Corneal Dystrophy Schnyder corneal dystrophy (SCD) is a rare, inherited eye disorder characterized by the accumulation of cholesterol and lipid deposits in the cornea, leading to progressive vision impairment. This condition is part of a group of disorders known as corneal dystrophies, which affect the clarity and function of the cornea.

Clinical Features[edit | edit source]

Schnyder corneal dystrophy typically presents with the following clinical features:

  • Corneal Opacification: Patients often develop a cloudy or opaque cornea due to lipid deposits. This can lead to decreased visual acuity.
  • Arcus Lipoides: A ring-like opacity, known as arcus lipoides, may form around the corneal periphery.
  • Crystalline Deposits: In some cases, crystalline deposits can be observed in the cornea, giving it a sparkling appearance.
  • Photophobia: Sensitivity to light is a common symptom due to corneal changes.

Genetics[edit | edit source]

Schnyder corneal dystrophy is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. The condition is associated with mutations in the UBIAD1 gene, which plays a role in cholesterol metabolism.

Diagnosis[edit | edit source]

Diagnosis of SCD is based on clinical examination and family history. Key diagnostic tools include:

Differential Diagnosis[edit | edit source]

Schnyder corneal dystrophy should be differentiated from other corneal dystrophies, such as:

Management[edit | edit source]

There is no cure for Schnyder corneal dystrophy, but management focuses on alleviating symptoms and improving vision:

Prognosis[edit | edit source]

The progression of Schnyder corneal dystrophy varies among individuals. While some may experience significant vision loss, others maintain relatively good vision throughout life. Regular monitoring by an ophthalmologist is essential.

Research and Future Directions[edit | edit source]

Ongoing research aims to better understand the genetic and biochemical pathways involved in SCD. Potential future therapies may include gene therapy or targeted treatments to reduce lipid accumulation in the cornea.

See Also[edit | edit source]

External Links[edit | edit source]

NIH genetic and rare disease info[edit source]

Schnyder corneal dystrophy is a rare disease.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD